CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
Multidisciplinary collaborative care armother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04660188
NCT04660188N/ACompleted

Impact of a Breast cAncer Survivorship Interprofessional Community Care Model (BASIC): A Randomized Controlled Trial

National Cancer Centre, Singapore·interventional·Posted Dec 9, 2020·Updated Nov 23, 2022

In Brief

A clinical study evaluating Multidisciplinary collaborative care arm for Survivorship and Breast Cancer. Completed, enrolled 70 participants across 1 site.

Detailed Summary

With an increase in breast cancer survivors (BCS) in Singapore, the current oncologist-centric survivorship model will not be sustainable to respond to the rising demand of survivorship care services. To meet the long-term healthcare needs of Singaporeans in a sustainable manner, the investigators propose to pilot a breast cancer survivorship inter-professional community (BASIC) care model for cancer survivorship. This pilot study aims to assess the feasibility and acceptability of this care model for implementation among BCS and healthcare providers. The investigators hypothesize that the BASIC model is feasible and acceptable to be evaluated on a larger scale. This new follow-up model can potentially reduce waiting times in tertiary centers without compromising quality of care, directly benefiting participants through more efficient follow-up sessions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSingapore

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 9, 2020
Enrollment StartMar 1, 2021
Primary CompletionJul 20, 2022
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 5.6 years ago

Interventions

Multidisciplinary collaborative care armother

Study participants will be cared for by a team of healthcare professionals; an oncologist, a PCP and a pharmacist navigator.